Applicant, as named in the Orange Book

Sarepta Theraps Inc

Next listed expiry: Vyondys 53 on 28 Jun 2028. 3 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Vyondys 53 NDA 211970 golodirsen	golodirsen	28 Jun 2028 patent	patent
Amondys 45 NDA 213026 casimersen	casimersen	12 Nov 2030 patent	patent
Exondys 51 NDA 206488 · 2 strengths eteplirsen	eteplirsen	14 Mar 2034 patent, carve-out possible	patent, carve-out possible

Vyondys 53 · Exclusivity expires within 90 days ODE-280Exclusivity expires 12 Dec 2026Detected 24 Oct 2026